Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Oncology Reports|February 11, 2012
Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapyCharles C L Tong, K H Vincent Lau, Michael Rivera, et al.
The Journal of Clinical Endocrinology and Metabolism|September 27, 2014
Clinical and molecular features of Hürthle cell carcinoma of the thyroidAna-Maria Chindris, John D Casler, Victor J Bernet, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2023
Long-term trends in human body size track regional variation in subsistence transitions and growth acceleration linked to dairyingJay T Stock, Emma Pomeroy, Christopher B Ruff, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|March 28, 2016
High-grade transformation of acinic cell carcinoma: an inadequately treated entity?Ashish V Chintakuntlawar, Wonwoo Shon, Michele Erickson-Johnson, et al.
The Journal of Clinical Endocrinology and Metabolism|December 4, 2013
RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinomaRobert C Smallridge, Ana-Maria Chindris, Yan W Asmann, et al.
Frontiers in Endocrinology|December 24, 2024
BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppressionAna-Maria Sigarteu Chindris, Michael Rivera, Yaohua Ma, et al.
Practical Radiation Oncology|October 29, 2021
Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive ChemoradiotherapyRobert W Gao, Robert L Foote, Yolanda I Garces, et al.
The Journal of Clinical Endocrinology and Metabolism|January 28, 2015
MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinomaKatayoon Kasaian, Ana-Maria Chindris, Sam M Wiseman, et al.
American Journal of Clinical Pathology|July 16, 2019
Assessment of The Bethesda System for Reporting Thyroid CytopathologyJennifer L Sauter, Heidi Lehrke, Xiaotun Zhang, et al.
Thyroid : Official Journal of the American Thyroid Association|October 10, 2019
A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid CancerAshish V Chintakuntlawar, Jun Yin, Robert L Foote, et al.
Pageof 7